Jazz Pharmaceuticals plc·4

Mar 9, 5:31 PM ET

COZADD BRUCE C 4

4 · Jazz Pharmaceuticals plc · Filed Mar 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Jazz Pharmaceuticals (JAZZ) Director Bruce C. Cozadd Shares Withheld for Taxes

What Happened
Bruce C. Cozadd, a director of Jazz Pharmaceuticals (JAZZ), had 15,114 shares disposed on March 5, 2026 as tax withholding related to the vesting of previously granted restricted stock units (RSUs). The withholding was calculated at $188.69 per share, resulting in a value of approximately $2,851,861. This was not an open-market sale but a routine disposition to satisfy tax obligations.

Key Details

  • Transaction date: 2026-03-05; filing date: 2026-03-09 (timely filed within required business-day window).
  • Shares withheld/disposed: 15,114 at $188.69 per share; total ≈ $2,851,861.
  • Transaction code: F (payment of exercise price or tax liability).
  • Footnote: Shares were withheld to satisfy tax obligations arising from vesting of a portion of previously granted RSUs.
  • Shares owned after the transaction: not specified in the provided filing.

Context
Tax-withholding dispositions on RSU vesting are routine and do not represent a market sale or necessarily signal a change in the insider’s view of the company. Transaction code F indicates shares were surrendered to cover taxes (a cashless/withholding mechanism), not sold on the open market.

Insider Transaction Report

Form 4
Period: 2026-03-05
Transactions
  • Tax Payment

    Ordinary Shares

    [F1]
    2026-03-05$188.69/sh15,114$2,851,861390,682 total
Footnotes (1)
  • [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
Signature
By: /s/Paz Dizon, as attorney in fact For: Bruce C. Cozadd|2026-03-09

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT